DrugPatentWatch Database Preview
Drugs in Development Information for PBT-1033
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug PBT-1033?
PBT-1033 is an investigational drug.
There have been 5 clinical trials for PBT-1033.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2019.
The most common disease conditions in clinical trials are Esophageal Neoplasms, Migraine Disorders, and Carcinoma, Squamous Cell. The leading clinical trial sponsors are GlaxoSmithKline, xjpfW, and NRG Oncology.
There are seven US patents protecting this investigational drug and sixty-five international patents.
Summary for PBT-1033
| US Patents | 7 |
| International Patents | 65 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2019-02-01) |
| Vendors | 9 |
Recent Clinical Trials for PBT-1033
| Title | Sponsor | Phase |
|---|---|---|
| Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | National Cancer Institute (NCI) | Phase 3 |
| Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | NRG Oncology | Phase 3 |
| Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy | xjpfW | N/A |
Clinical Trial Summary for PBT-1033
Top disease conditions for PBT-1033
Top clinical trial sponsors for PBT-1033
US Patents for PBT-1033
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| PBT-1033 | Start Trial | Parkin ligase activation methods and compositions | AN2H DISCOVERY LIMITED (Dublin, IE) | Start Trial |
| PBT-1033 | Start Trial | 8-hydroxy quinoline derivatives | Prana Biotechnology Limited (AU) | Start Trial |
| PBT-1033 | Start Trial | Use of pyridopyrimidine compounds in the treatment of gliomas | Prana Biotechnology Limited (Parkville, Victoria, AU) | Start Trial |
| PBT-1033 | Start Trial | 8-hydroxy quinoline derivatives | Prana Biotechnology Limited (Parkville, Victoria, AU) | Start Trial |
| PBT-1033 | Start Trial | Method of treatment of age-related macular degeneration (AMD) | PRANA BIOTECHNOLOGY INC. (Parkville, Victoria, AU) | Start Trial |
| PBT-1033 | Start Trial | 8-hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (Parkville, Victoria, AU) | Start Trial |
| PBT-1033 | Start Trial | 8-hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (Victoria, AU) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for PBT-1033
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| PBT-1033 | Australia | 2015357487 | 2034-12-05 | Start Trial |
| PBT-1033 | Brazil | 112017011644 | 2034-12-05 | Start Trial |
| PBT-1033 | Canada | 2968094 | 2034-12-05 | Start Trial |
| PBT-1033 | China | 107249580 | 2034-12-05 | Start Trial |
| PBT-1033 | European Patent Office | 3227437 | 2034-12-05 | Start Trial |
| PBT-1033 | Israel | 252425 | 2034-12-05 | Start Trial |
| PBT-1033 | Japan | 2017538699 | 2034-12-05 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
